Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

JNJ PFE NVS SNY Wireless Management Basic Utilities Aggressive 
Benchmark SP 500  1,652   12.77  Index Moved Up 0.78% United States ...


Processing
Collecting data for AEGR

Aegerion performance

 
 Companies |  Insiders  | Dashboard  
     

Aegerion Pharmaceuticals

Stock@NASDAQ 
United States USD
 
(68.74 M)
    
On a scale of 0 to 100 Aegerion holds performance score of 4. The organization shows Beta (market volatility) of -1.21 which signifies that as returns on market increase, returns on owning Aegerion are expected to decrease by larger amounts. On the other hand, during market turmoil, Aegerion is expected to significantly outperform it. Although it is vital to follow to Aegerion Pharmaceuticals historical returns, it is good to be conservative about what you can actually do with the information about equity current trading patterns. The philosophy in foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing Aegerion Pharmaceuticals technical indicators you can presently evaluate if the expected return of 0.36% will be sustainable into the future. Please makes use of Aegerion Pharmaceuticals Variance as well as the relationship between Value At Risk and Skewness to make a quick decision on weather Aegerion price patterns will revert.
change horizon
Investment horizon: 
  30 Days    Login   to change

Relative Risk vs. Return Landscape

If you would invest  6,002  in Aegerion Pharmaceuticals Inc on May 20, 2013 and sell it today you would earn a total of  368.00  from holding Aegerion Pharmaceuticals Inc or generate 6.13% return on investment over 30 days. Aegerion Pharmaceuticals Inc is currenly generating 0.36% of daily expected returns and assumes 4.24% risk (volatility on return distribution) over the 30 days horizon. In different words, 52% of equities are less volatile than Aegerion Pharmaceuticals Inc and 85% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
Daily Expected Return (%)
 
Change Benchmark  Embed  Export  Risk [Daily Volatility] (%)
Given investment horizon of 30 days, Aegerion Pharmaceuticals Inc is expected to generate 5.05 times more return on investment than the market. However, the company is 5.05 times more volatile than its market benchmark. It trades about 0.08 of its potential returns per unit of risk. The S&P 500 is currently generating roughly -0.05 per unit of risk.

Aegerion Return On Equity vs Return On Asset

Aegerion Pharmaceuticals Inc is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies .
Aegerion
Performance
4
Out Of
100
Over 30
Days
96% of all equities and portfolios perform better than Aegerion Pharmaceuticals Inc. Compared with the overall equity markets, risk-adjusted returns on investments in Aegerion Pharmaceuticals Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 30 days.
Embed widgets for Aegerion
Financial widgets and gadgets
Live stock tickers for equities

1 Month Efficiency (a.k Sharpe Ratio) ...

0.08

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsAEGR
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns

Estimated Market Risk

 4.24
  actual daily
 
 48 %
of total potential
 
Market Risk score

Expected Return

 0.36
  actual daily
 
 15 %
of total potential
 
Expected Return score

Risk-Adjusted Return

 0.08
  actual daily
 
 4 %
of total potential
 
Risk-Adjusted Return score
Based on monthly moving average Aegerion is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aegerion by adding it to a well-diversified portfolio.

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium